Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.78 USD | +4.06% | +0.68% | -45.64% |
Business Summary
Number of employees: 487
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Medicines
100.0
%
| 8 | 100.0 % | 86 | 100.0 % | +1,024.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 8 | 100.0 % | 86 | 100.0 % | +1,024.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Mike Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Laura Gault
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-30 |
Matt Lasmanis
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-31 |
Amy Schacterle
COO | Chief Operating Officer | - | 15-02-12 |
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Tammy J. Phinney
LAW | General Counsel | - | 20-07-31 |
Vanessa Procter
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Jim Frates
BRD | Director/Board Member | 56 | 14-04-30 |
Michael Cola
BRD | Director/Board Member | 64 | 14-09-10 |
Geno Germano
CHM | Chairman | 63 | 16-07-18 |
Director/Board Member | 67 | 19-01-22 | |
Director/Board Member | 62 | 19-01-22 | |
Jessica Federer
BRD | Director/Board Member | - | 23-03-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 60,185,064 | 52,677,105 ( 87.53 %) | 3,033 ( 0.005039 %) | 87.53 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.64% | 709M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- SAGE Stock
- Company Sage Therapeutics, Inc.